Tag Archives: NASDAQ:RGLS

Regulus (RGLS) Receives a Hold from Wedbush

Wedbush analyst Liana Moussatos reiterated a Hold rating on Regulus (RGLS – Research Report) today and set a price target of $1. The company’s shares opened today at $1.32, close to its 52-week low of $0.80. According to TipRanks.com, Moussatos

Wedbush Reiterates Their Hold Rating on Regulus (RGLS)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Regulus (RGLS – Research Report) today and set a price target of $2. The company’s shares opened today at $1.08, close to its 52-week low of $0.80. According to TipRanks.com, Moussatos

Regulus (RGLS) Receives a Hold from Needham

In a report released today, Alan Carr from Needham maintained a Hold rating on Regulus (RGLS – Research Report). The company’s shares opened today at $2, close to its 52-week low of $1.71. Carr wrote: “Regulus announced this morning another

Wedbush Reiterates a Hold Rating on Regulus (RGLS)

In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Regulus (NASDAQ: RGLS), with a price target of $2.34. The company’s shares opened today at $2.38, close to its 52-week low of $2.03. According to TipRanks.com,

Regulus (RGLS) Gets a Hold Rating from B.Riley FBR

In a report released today, Madhu Kumar from B.Riley FBR reiterated a Hold rating on Regulus (NASDAQ: RGLS), with a price target of $0.25. The company’s shares opened today at $0.20, close to its 52-week low of $0.17. Kumar wrote:

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Regulus (NASDAQ: RGLS), Perrigo Company plc (NYSE: PRGO) and Spero Therapeutics Inc (NASDAQ: SPRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regulus (NASDAQ:RGLS), Perrigo Company plc (NYSE:PRGO) and Spero Therapeutics Inc (NASDAQ:SPRO). Regulus (RGLS) In a report released yesterday, Liana Moussatos from Wedbush reiterated